Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: Investigation of renin-angiotensin system genes

Journal of Hypertension

Volumn 14, Issue 2, 1996, Pages 259-262

  Dudley, Christopher ^a   Keavney, Bernard ^a,b   Casadei, Barbara ^a   Conway, James ^a   Bird, Rosemary ^a   Ratcliffe, Peter ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ambulatory blood pressure; Genetic polymorphism; Hypertension; Renin angiotensin system; Response to treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; LISINOPRIL; NIFEDIPINE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG RESPONSE; ESSENTIAL HYPERTENSION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

EID: 0029880851     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199602000-00016     Document Type: Article

References (12)

1. Bidiville J, Nussberger J, Waeber G, Porchet M, Waeber B, Brunner HR: Individual responses to converting enzyme Inhibitors and calcium antagonists. Hypertension 1988, 11:166-173.
2. Attwood S, Bird R, Burch K, Casadei B, Coats A, Conway J, et al. : Within patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine. J Hypertens 1994, 12:1053-1060.
3. Laragh JH: Renin profiling for diagnosis, risk assessment, and treatment of hypertension. Kidney Int 1993, 44:1163-1175.
4. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase). Nucleic Acids Res 1992, 20:1433.
5. Shanmugan V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Appl 1993, 3:120-121.
6. RUSS AP, Maerz W, Ruzicka V, Stein U, Grass W: Rapid detection of the hypertension-associated Met235-Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993, 2:609-610.
7. Cambien F, Poiroer O, Lecerf L, Evans A, Cambou J-P, Arvelier D, et al.: Deletion polymorphism in the gene for angiotensin-converttng enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644.
8. Schunkert H, Hense H-W, Holmer SR, Stender M, Perz S, Keil U, et al.: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 330:1634-1638
9. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An Insertion/deletion polymorphism in the angiotensin-1 -converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
10. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al.: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169-180.
11. Armitage P, Berry G: Statistical Methods in Medical Research, 3rd edn. Oxford: Blackwell Scientific Publications; 1994:197.
12. Armitage P, Berry G: Statistical Methods in Medical Research, 3rd edn. Oxford: Blackwell Scientific Publications; 1994:116, 165.